SE9000948D0 - New use - Google Patents

New use

Info

Publication number
SE9000948D0
SE9000948D0 SE9000948A SE9000948A SE9000948D0 SE 9000948 D0 SE9000948 D0 SE 9000948D0 SE 9000948 A SE9000948 A SE 9000948A SE 9000948 A SE9000948 A SE 9000948A SE 9000948 D0 SE9000948 D0 SE 9000948D0
Authority
SE
Sweden
Prior art keywords
new use
bambuterol
manufacture
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
SE9000948A
Other languages
English (en)
Swedish (sv)
Inventor
C-A W E Bauer
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Priority to SE9000948A priority Critical patent/SE9000948D0/xx
Publication of SE9000948D0 publication Critical patent/SE9000948D0/xx
Priority to ZA911452A priority patent/ZA911452B/xx
Priority to NZ237279A priority patent/NZ237279A/en
Priority to IL9750991A priority patent/IL97509A/en
Priority to MYPI91000414A priority patent/MY114218A/en
Priority to EG14791A priority patent/EG19645A/xx
Priority to EP91906760A priority patent/EP0521967B1/en
Priority to JP03507053A priority patent/JP3081640B2/ja
Priority to AU75691/91A priority patent/AU653149B2/en
Priority to HU9202958A priority patent/HU211998B/hu
Priority to DE69119896T priority patent/DE69119896T2/de
Priority to ES91906760T priority patent/ES2087291T3/es
Priority to CA002077762A priority patent/CA2077762C/en
Priority to SU915053006A priority patent/RU2093153C1/ru
Priority to PCT/SE1991/000195 priority patent/WO1991013615A1/en
Priority to AT91906760T priority patent/ATE138570T1/de
Priority to SG1996005904A priority patent/SG64895A1/en
Priority to DK91906760.3T priority patent/DK0521967T3/da
Priority to SK681-91A priority patent/SK278815B6/sk
Priority to IE86291A priority patent/IE80668B1/en
Priority to CS91681A priority patent/CZ279308B6/cs
Priority to US07/670,053 priority patent/US5837727A/en
Priority to PT97052A priority patent/PT97052B/pt
Priority to KR1019920702222A priority patent/KR100194995B1/ko
Priority to LVP-93-816A priority patent/LV10917B/lv
Priority to LTIP1735A priority patent/LT3734B/lt
Priority to GR960402068T priority patent/GR3020700T3/el
Priority to HK52197A priority patent/HK52197A/xx
Priority to US09/193,940 priority patent/US6034123A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SE9000948A 1990-03-16 1990-03-16 New use SE9000948D0 (sv)

Priority Applications (29)

Application Number Priority Date Filing Date Title
SE9000948A SE9000948D0 (sv) 1990-03-16 1990-03-16 New use
ZA911452A ZA911452B (en) 1990-03-16 1991-02-27 New use of 5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene-bis(dimethylcarbanate)
NZ237279A NZ237279A (en) 1990-03-16 1991-03-01 Preparation and use of a lipid-lowering active composition comprising bambuterol
IL9750991A IL97509A (en) 1990-03-16 1991-03-11 Preparations that lower the level of lipids that contain ambutrol
MYPI91000414A MY114218A (en) 1990-03-16 1991-03-13 The use of bambuterol or a pharmaceutically acceptable salt thereof, to make lipid lowering pharmaceutical preparations.
EG14791A EG19645A (en) 1990-03-16 1991-03-13 A method for preparing pharmaceutical by use bambuterol
JP03507053A JP3081640B2 (ja) 1990-03-16 1991-03-14 バムブテロールを含む脂質低下用医薬組成物
CA002077762A CA2077762C (en) 1990-03-16 1991-03-14 New use of bambuterol
DK91906760.3T DK0521967T3 (da) 1990-03-16 1991-03-14 Ny anvendelse af bambuterol
AU75691/91A AU653149B2 (en) 1990-03-16 1991-03-14 New use of bambuterol
HU9202958A HU211998B (en) 1990-03-16 1991-03-14 Process to prepare pharmaceutical compns. contg. bambuterol with lipid lowering effect
DE69119896T DE69119896T2 (de) 1990-03-16 1991-03-14 Neue verwendung von bambuterol
ES91906760T ES2087291T3 (es) 1990-03-16 1991-03-14 Nuevo uso de bambuterol.
EP91906760A EP0521967B1 (en) 1990-03-16 1991-03-14 New use of bambuterol
SU915053006A RU2093153C1 (ru) 1990-03-16 1991-03-14 5-[2-(трет-бутиламино)-1-гидроксиэтил]-м-фенилен-бис(диметилкарбамат)(бамбутерин) в качестве липидопонижающего препарата и фармацевтическая композиция на основе бамбутерина
PCT/SE1991/000195 WO1991013615A1 (en) 1990-03-16 1991-03-14 New use of bambuterol
AT91906760T ATE138570T1 (de) 1990-03-16 1991-03-14 Neue verwendung von bambuterol
SG1996005904A SG64895A1 (en) 1990-03-16 1991-03-14 New use of bambuterol
SK681-91A SK278815B6 (sk) 1990-03-16 1991-03-15 Použitie bambuterolu alebo jeho farmaceuticky prij
PT97052A PT97052B (pt) 1990-03-16 1991-03-15 Processo para a preparacao de composicoes farmaceuticas contendo bambuterol, apropriadas para diminuir o teor de lipidos no sangue
IE86291A IE80668B1 (en) 1990-03-16 1991-03-15 New use of bambuterol
CS91681A CZ279308B6 (cs) 1990-03-16 1991-03-15 Použití bambuterolu nebo jeho farmaceuticky přijatelné soli k výrobě farmaceutického prostředku s účinky snižujícími hladinu lipidů a farmaceutický prostředek je obsahující
US07/670,053 US5837727A (en) 1990-03-16 1991-03-15 Method for altering blood lipid levels
KR1019920702222A KR100194995B1 (ko) 1990-03-16 1992-09-15 관상동맥성 심장질환,동맥경화증 및(또는)지방단백질 대사 이상 치료용 약제
LVP-93-816A LV10917B (en) 1990-03-16 1993-06-30 New use of bambuterol
LTIP1735A LT3734B (en) 1990-03-16 1993-12-30 Use of bambuterol for the manufacture of a pharmaceutical preparation with lipid lowering effect
GR960402068T GR3020700T3 (en) 1990-03-16 1996-07-31 New use of bambuterol
HK52197A HK52197A (en) 1990-03-16 1997-04-24 New use of bambuterol
US09/193,940 US6034123A (en) 1990-03-16 1998-11-17 Method for altering blood lipid levels

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9000948A SE9000948D0 (sv) 1990-03-16 1990-03-16 New use

Publications (1)

Publication Number Publication Date
SE9000948D0 true SE9000948D0 (sv) 1990-03-16

Family

ID=20378886

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9000948A SE9000948D0 (sv) 1990-03-16 1990-03-16 New use

Country Status (28)

Country Link
US (2) US5837727A (ko)
EP (1) EP0521967B1 (ko)
JP (1) JP3081640B2 (ko)
KR (1) KR100194995B1 (ko)
AT (1) ATE138570T1 (ko)
AU (1) AU653149B2 (ko)
CA (1) CA2077762C (ko)
CZ (1) CZ279308B6 (ko)
DE (1) DE69119896T2 (ko)
DK (1) DK0521967T3 (ko)
EG (1) EG19645A (ko)
ES (1) ES2087291T3 (ko)
GR (1) GR3020700T3 (ko)
HK (1) HK52197A (ko)
HU (1) HU211998B (ko)
IE (1) IE80668B1 (ko)
IL (1) IL97509A (ko)
LT (1) LT3734B (ko)
LV (1) LV10917B (ko)
MY (1) MY114218A (ko)
NZ (1) NZ237279A (ko)
PT (1) PT97052B (ko)
RU (1) RU2093153C1 (ko)
SE (1) SE9000948D0 (ko)
SG (1) SG64895A1 (ko)
SK (1) SK278815B6 (ko)
WO (1) WO1991013615A1 (ko)
ZA (1) ZA911452B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9000948D0 (sv) * 1990-03-16 1990-03-16 Draco Ab New use
US6459316B1 (en) * 2000-12-08 2002-10-01 Intel Corporation Flip flop circuit
US7067517B2 (en) * 2001-12-14 2006-06-27 Nero Nordisk A/S Use of compounds for decreasing activity of hormone-sensitive lipase
US7495028B2 (en) 2002-08-08 2009-02-24 Wen Tan R-bambuterol, its preparation and therapeutic uses
AU2002332488A1 (en) * 2002-08-08 2004-02-25 J. L. Cheng R-bambuterol, its preparation and therapeutic uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043807B1 (en) * 1980-07-09 1984-05-30 Aktiebolaget Draco 1-(dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates
US4472436A (en) * 1982-12-06 1984-09-18 Neo-Bionics, Inc. Increasing HDL-cholesterol levels with phenylethylamine derivatives
EP0244062A3 (en) * 1986-03-03 1990-06-20 Beecham Group Plc Use of aryl ethanol amine derivatives in the treatment of atherosclerosis
SE9000948D0 (sv) * 1990-03-16 1990-03-16 Draco Ab New use

Also Published As

Publication number Publication date
DE69119896T2 (de) 1996-10-10
JPH05504971A (ja) 1993-07-29
ATE138570T1 (de) 1996-06-15
SG64895A1 (en) 2000-01-25
LT3734B (en) 1996-02-26
AU653149B2 (en) 1994-09-22
PT97052B (pt) 1998-07-31
LV10917B (en) 1996-04-20
GR3020700T3 (en) 1996-10-31
WO1991013615A1 (en) 1991-09-19
HUT61461A (en) 1993-01-28
KR100194995B1 (ko) 1999-06-15
LV10917A (lv) 1995-12-20
NZ237279A (en) 1993-08-26
MY114218A (en) 2002-09-30
IL97509A0 (en) 1992-06-21
ZA911452B (en) 1991-11-27
EP0521967A1 (en) 1993-01-13
JP3081640B2 (ja) 2000-08-28
ES2087291T3 (es) 1996-07-16
EG19645A (en) 1995-09-30
DK0521967T3 (da) 1996-09-09
CA2077762C (en) 2001-06-12
CS9100681A2 (en) 1991-10-15
CZ279308B6 (cs) 1995-04-12
HU211998B (en) 1996-01-29
PT97052A (pt) 1991-10-31
SK278815B6 (sk) 1998-03-04
HU9202958D0 (en) 1992-12-28
LTIP1735A (en) 1995-07-25
HK52197A (en) 1997-05-02
IE80668B1 (en) 1998-11-18
DE69119896D1 (de) 1996-07-04
EP0521967B1 (en) 1996-05-29
RU2093153C1 (ru) 1997-10-20
US6034123A (en) 2000-03-07
AU7569191A (en) 1991-10-10
US5837727A (en) 1998-11-17
IL97509A (en) 1995-12-31
IE910862A1 (en) 1991-09-25
CA2077762A1 (en) 1991-09-17

Similar Documents

Publication Publication Date Title
NO904694L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO901684D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
MX9101175A (es) Composicion farmaceutica para administracion nasal
NO914667L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylderivater
ES510348A0 (es) "procedimiento de preparacion de nuevos derivados 3,4-dihidro-5h-2,3-benzodiazepinos y de sus sales de adicion acidas farmaceuticamente aceptables".
NO910935L (no) Fremgangsmaate for fremstilling av terapeutisk aktive c-bundne pyrazol-derivater.
SE9000948D0 (sv) New use
NO905327L (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbamoylderivater.
NO913187D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater.
ES551866A0 (es) Procedimiento de preparacion de nuevos derivados alquilamino-furanonas y de sales y diastereoisomeros farmaceuticamente aceptables de los mismos.
NO891574D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
IS3743A7 (is) Ný notkun á 5-(2 klóró-1-hýdroxíetýl)-4-metýlþíasól
NO900972D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
NO900942D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater.
JO1692B1 (en) Use of a pharmaceutically acceptable salt
SE9000288D0 (sv) New use
SE9304236D0 (sv) New use
NO890506D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kloranilin-derivater.
NO891677L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater.
RO76155A2 (ro) Medicament hipoglicemiant oral
NO922645D0 (no) Anvendelse av lokale anestesimidler for fremstilling av farmasoeytiske preparater for iontoforese